|
Status |
Public on Oct 07, 2014 |
Title |
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
ETS1 and RAS/ERK regulate a common gene expression program in establishing enviroment suitable for prostate cancer cell migration.
|
|
|
Overall design |
mRNA profiles of luciferase knockdown (WT), ETS1 knockdown, and U0126 treated DU145 cells were generated using deep sequencing, in triplicate, using Illumina HiSeq. Knockdowns were stable shRNA expression from a lentiviral construct selected with puromycin.
|
|
|
Contributor(s) |
Plotnik JP, Budka JA, Hollenhorst PC |
Citation(s) |
25294825, 28119415 |
|
Submission date |
Jul 02, 2014 |
Last update date |
May 15, 2019 |
Contact name |
Josh Plotnik |
E-mail(s) |
joshua.plotnik@abbvie.com
|
Organization name |
AbbVie Inc.
|
Street address |
1 North Waukegan Rd, AP10/210A
|
City |
North Chicago |
State/province |
IL |
ZIP/Postal code |
60064 |
Country |
USA |
|
|
Platforms (1) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
Samples (9)
|
GSM1424515 |
Luciferase knockdown in DU145 cells using shRNA replicate 1 |
GSM1424516 |
Luciferase knockdown in DU145 cells using shRNA replicate 2 |
GSM1424517 |
Luciferase knockdown in DU145 cells using shRNA replicate 3 |
GSM1424518 |
ETS1 knockdown in DU145 cells using shRNA replicate 1 |
GSM1424519 |
ETS1 knockdown in DU145 cells using shRNA replicate 2 |
GSM1424520 |
ETS1 knockdown in DU145 cells using shRNA replicate 3 |
GSM1424521 |
U0126 treated DU145 cells replicate 1 |
GSM1424522 |
U0126 treated DU145 cells replicate 2 |
GSM1424523 |
U0126 treated DU145 cells replicate 3 |
|
This SubSeries is part of SuperSeries: |
GSE59022 |
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells |
|
Relations |
BioProject |
PRJNA254145 |
SRA |
SRP044013 |